Medpace Holdings, Inc. Interest Income (Expense), Nonoperating, Net
Medpace Holdings, Inc. (MEDP) reported Interest Income (Expense), Nonoperating, Net of $4.99 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2026-07-23
- Medpace Holdings, Inc. interest income (expense), nonoperating, net for the quarter ending 2026-06-30 was $4.99M, a 362.52% increase year-over-year.
- Medpace Holdings, Inc. interest income (expense), nonoperating, net for the quarter ending 2026-03-31 was $5.12M, a 20.83% decline year-over-year.
- Medpace Holdings, Inc. interest income (expense), nonoperating, net for the quarter ending 2025-12-31 was $3.72M, a 52.78% decline year-over-year.
- Medpace Holdings, Inc. interest income (expense), nonoperating, net for the quarter ending 2025-09-30 was $1.52M, a 79.85% decline year-over-year.
- Medpace Holdings, Inc. interest income (expense), nonoperating, net for fiscal 2025 was $12.78M, a 48.87% decline from fiscal 2024.
- Medpace Holdings, Inc. interest income (expense), nonoperating, net for fiscal 2024 was $25.00M.
- Medpace Holdings, Inc. interest income (expense), nonoperating, net for fiscal 2023 was -$488.00K.
- Medpace Holdings, Inc. interest income (expense), nonoperating, net for fiscal 2022 was -$2.90M.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.99M 10-Q · filed 2026-07-23 | $10.10M 10-Q · filed 2026-07-23 | $13.82M derived: sum of 3 quarters · filed 2026-07-23 | $15.34M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $5.12M 10-Q · filed 2026-04-23 | $8.84M derived: sum of 2 quarters · filed 2026-04-23 | $10.36M derived: sum of 3 quarters · filed 2026-04-23 | $11.43M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $3.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $5.24M derived: sum of 2 quarters · filed 2026-02-10 | $6.32M derived: sum of 3 quarters · filed 2026-07-23 | $12.78M 10-K · filed 2026-02-10 |
| 2025-09-30 | $1.52M 10-Q · filed 2025-10-23 | $2.60M derived: sum of 2 quarters · filed 2026-07-23 | $9.06M 10-Q · filed 2025-10-23 | $16.94M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $1.08M 10-Q · filed 2026-07-23 | $7.54M 10-Q · filed 2026-07-23 | $15.42M derived: sum of 3 quarters · filed 2026-07-23 | $22.95M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $6.46M 10-Q · filed 2026-04-23 | $14.35M derived: sum of 2 quarters · filed 2026-04-23 | $21.87M derived: sum of 3 quarters · filed 2026-04-23 | $27.34M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | $7.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $15.41M derived: sum of 2 quarters · filed 2026-02-10 | $20.88M derived: sum of 3 quarters · filed 2026-02-10 | $25.00M 10-K · filed 2026-02-10 |
| 2024-09-30 | $7.53M 10-Q · filed 2025-10-23 | $12.99M derived: sum of 2 quarters · filed 2025-10-23 | $17.11M 10-Q · filed 2025-10-23 | $18.96M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $5.46M 10-Q · filed 2025-07-22 | $9.59M 10-Q · filed 2025-07-22 | $11.43M derived: sum of 3 quarters · filed 2026-02-10 | $11.32M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $4.12M 10-Q · filed 2025-04-22 | $5.96M derived: sum of 2 quarters · filed 2026-02-10 | $5.86M derived: sum of 3 quarters · filed 2026-02-10 | $4.49M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $1.74M derived: sum of 2 quarters · filed 2026-02-10 | $373.00K derived: sum of 3 quarters · filed 2026-02-10 | -$488.00K 10-K · filed 2026-02-10 |
| 2023-09-30 | -$105.00K 10-Q · filed 2024-10-22 | -$1.47M derived: sum of 2 quarters · filed 2024-10-22 | -$2.33M 10-Q · filed 2024-10-22 | -$3.16M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | -$1.37M 10-Q · filed 2024-07-23 | -$2.23M 10-Q · filed 2024-07-23 | -$3.05M derived: sum of 3 quarters · filed 2025-02-11 | -$4.64M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | -$861.00K 10-Q · filed 2024-04-23 | -$1.69M derived: sum of 2 quarters · filed 2025-02-11 | -$3.27M derived: sum of 3 quarters · filed 2025-02-11 | -$3.82M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | -$827.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | -$2.41M derived: sum of 2 quarters · filed 2025-02-11 | -$2.96M derived: sum of 3 quarters · filed 2025-02-11 | -$2.90M 10-K · filed 2025-02-11 |
| 2022-09-30 | -$1.58M 10-Q · filed 2023-10-24 | -$2.13M derived: sum of 2 quarters · filed 2023-10-24 | -$2.08M 10-Q · filed 2023-10-24 | -$2.10M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | -$548.00K 10-Q · filed 2023-07-25 | -$494.00K 10-Q · filed 2023-07-25 | -$517.00K derived: sum of 3 quarters · filed 2024-02-13 | -$558.00K derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $54.00K 10-Q · filed 2023-04-25 | $31.00K derived: sum of 2 quarters · filed 2024-02-13 | -$10.00K derived: sum of 3 quarters · filed 2024-02-13 | -$37.00K derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | -$23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | -$64.00K derived: sum of 2 quarters · filed 2024-02-13 | -$91.00K derived: sum of 3 quarters · filed 2024-02-13 | -$105.00K 10-K · filed 2024-02-13 |
| 2021-09-30 | -$41.00K 10-Q · filed 2022-10-25 | -$68.00K derived: sum of 2 quarters · filed 2022-10-25 | -$82.00K 10-Q · filed 2022-10-25 | -$111.00K derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | -$27.00K 10-Q · filed 2022-07-26 | -$41.00K 10-Q · filed 2022-07-26 | -$70.00K derived: sum of 3 quarters · filed 2023-02-14 | -$86.00K derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | -$14.00K 10-Q · filed 2022-04-26 | -$43.00K derived: sum of 2 quarters · filed 2023-02-14 | -$59.00K derived: sum of 3 quarters · filed 2023-02-14 | -$64.00K derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | -$29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | -$45.00K derived: sum of 2 quarters · filed 2023-02-14 | -$50.00K derived: sum of 3 quarters · filed 2023-02-14 | $307.00K 10-K · filed 2023-02-14 |
| 2020-09-30 | -$16.00K 10-Q · filed 2021-10-26 | -$21.00K derived: sum of 2 quarters · filed 2021-10-26 | $336.00K 10-Q · filed 2021-10-26 | $724.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | -$5.00K 10-Q · filed 2021-07-27 | $352.00K 10-Q · filed 2021-07-27 | $740.00K derived: sum of 3 quarters · filed 2022-02-15 | $487.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $357.00K 10-Q · filed 2021-04-27 | $745.00K derived: sum of 2 quarters · filed 2022-02-15 | $492.00K derived: sum of 3 quarters · filed 2022-02-15 | -$256.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $388.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $135.00K derived: sum of 2 quarters · filed 2022-02-15 | -$613.00K derived: sum of 3 quarters · filed 2022-02-15 | -$1.57M 10-K · filed 2022-02-15 |
| 2019-09-30 | -$253.00K 10-Q · filed 2020-10-27 | -$1.00M derived: sum of 2 quarters · filed 2020-10-27 | -$1.96M 10-Q · filed 2020-10-27 | -$3.56M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | -$748.00K 10-Q · filed 2020-07-28 | -$1.70M 10-Q · filed 2020-07-28 | -$3.30M derived: sum of 3 quarters · filed 2021-02-16 | -$5.24M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | -$955.00K 10-Q · filed 2020-04-29 | -$2.55M derived: sum of 2 quarters · filed 2021-02-16 | -$4.50M derived: sum of 3 quarters · filed 2021-02-16 | -$6.80M derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | -$1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | -$3.54M derived: sum of 2 quarters · filed 2021-02-16 | -$5.85M derived: sum of 3 quarters · filed 2021-02-16 | -$8.16M 10-K · filed 2021-02-16 |
| 2018-09-30 | -$1.94M 10-Q · filed 2019-10-29 | -$4.25M derived: sum of 2 quarters · filed 2019-10-29 | -$6.56M 10-Q · filed 2019-10-29 | -$8.61M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | -$2.31M 10-Q · filed 2019-07-30 | -$4.62M 10-Q · filed 2019-07-30 | -$6.67M derived: sum of 3 quarters · filed 2020-02-25 | -$8.57M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | -$2.31M 10-Q · filed 2019-04-30 | -$4.36M derived: sum of 2 quarters · filed 2020-02-25 | -$6.27M derived: sum of 3 quarters · filed 2020-02-25 | -$8.07M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | -$2.05M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$3.96M derived: sum of 2 quarters · filed 2020-02-25 | -$5.76M derived: sum of 3 quarters · filed 2020-02-25 | -$7.56M 10-K · filed 2020-02-25 |
| 2017-09-30 | -$1.91M 10-Q · filed 2018-10-30 | -$3.71M derived: sum of 2 quarters · filed 2018-10-30 | -$5.51M 10-Q · filed 2018-10-30 | -$8.34M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | -$1.81M 10-Q · filed 2018-07-31 | -$3.60M 10-Q · filed 2018-07-31 | -$6.44M derived: sum of 3 quarters · filed 2019-02-26 | -$11.09M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | -$1.79M 10-Q · filed 2018-05-01 | -$4.63M derived: sum of 2 quarters · filed 2019-02-26 | -$9.28M derived: sum of 3 quarters · filed 2019-02-26 | -$15.21M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | -$2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$7.49M derived: sum of 2 quarters · filed 2019-02-26 | -$13.41M derived: sum of 3 quarters · filed 2019-02-26 | -$19.38M 10-K · filed 2019-02-26 |
| 2016-09-30 | -$4.66M 10-Q · filed 2017-10-31 | -$10.58M derived: sum of 2 quarters · filed 2017-10-31 | -$16.55M 10-Q · filed 2017-10-31 | -$23.10M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | -$5.92M 10-Q · filed 2017-08-01 | -$11.89M 10-Q · filed 2017-08-01 | -$18.44M derived: sum of 3 quarters · filed 2018-02-27 | -$25.18M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | -$5.97M 10-Q · filed 2017-05-02 | -$12.52M derived: sum of 2 quarters · filed 2018-02-27 | -$19.26M derived: sum of 3 quarters · filed 2018-02-27 | |
| 2015-12-31 | -$6.55M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$13.28M derived: sum of 2 quarters · filed 2018-02-27 | -$27.26M 10-K · filed 2018-02-27 | |
| 2015-09-30 | -$6.74M 10-Q · filed 2016-11-03 | -$20.71M 10-Q · filed 2016-11-03 | ||
| 2014-12-31 | -$23.18M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |